Product Name | MF | CAS | Details |
---|
MDM2-IN-1 | C23H21Cl2FN2O3 | 1410737-09-5 | Details |
CBP/p300-IN-2 | C27H29F2N7O2 | 2158265-96-2 | Details |
CCR1 antagonist 6 | C21H23ClN4O3S | 2436773-01-0 | Details |
BIIL-260 hydrochloride | C30H31ClN2O3 | 192581-24-1 | Details |
GF 15 | C23H21ClO6 | 888042-13-5 | Details |
GlyT1 Inhibitor 1 | C22H21N5O2 | 1820934-93-7 | Details |
H3B-6545 Hydrochloride | C30H30ClF4N5O2 | 2052132-51-9 | Details |
HIV-1 integrase inhibitor 7 | C30H26O16 | 204268-03-1 | Details |
MBM-17 | C28H28N6O2 | 2083621-90-1 | Details |
LY 222306 | C19H23N5O7 | 154446-98-7 | Details |
Etamicastat hydrochloride | C14H16ClF2N3OS | 677773-32-9 | Details |
BPH-652 | C16H16K3O7PS | 157124-84-0 | Details |
BMS-654457 | C36H37N5O4 | 1004551-41-0 | Details |
BLM-IN-1 | C28H35FN4O | 2056014-40-3 | Details |
c-Fms-IN-9 | C21H23N7O2 | 1628574-50-4 | Details |
CB2 modulator 1 | C18H19F3N4O2 | 666261-80-9 | Details |
BRL-42715 | C10H9N4NaO3S | 102209-75-6 | Details |
c-Met-IN-2 | C24H21FN10O | 1635406-73-3 | Details |
c-Kit-IN-2 | C25H29N9O2S | 2121515-37-3 | Details |
Foliglurax | C23H23N3O3S | 1883329-51-8 | Details |
HPN-01 | C19H16ClN3O3S | 928655-63-4 | Details |
DHODH-IN-14 | C15H7F4N3O3 | 1364791-93-4 | Details |
KRAS inhibitor-7 | C26H27ClF2N6O2 | 2022986-68-9 | Details |
Mcl1-IN-11 | C38H41N3O5S2 | 2042211-13-0 | Details |
Mcl1-IN-9 | C37H39ClN4O4 | 1810769-31-3 | Details |
MBM-55S | C32H33FN6O6 | 2083624-07-9 | Details |
KDOAM-25 citrate | C15H25N5O2.C6H8O7 | 2448475-08-7 | Details |
GPR120 Agonist 1 | C20H12ClF6NO3S | 1628448-77-0 | Details |
EGFR-IN-2 | C26H33N9O3S | 1643497-70-4 | Details |
DC_C66 | C28H22NO2+ | 108181-00-6 | Details |
DHODH-IN-13 | C10H6F3N3O3 | 1364791-86-5 | Details |
Derazantinib Racemate | C29H29FN4O | 2309668-44-6 | Details |
GKI-1 | C15H12ClN3 | 2444764-03-6 | Details |
G6PD activator AG1 | C24H30N4S2 | 421581-52-4 | Details |
HMG499 | C33H54O3 | 2416941-68-7 | Details |
DSP-0565 | C14H12FNO | 1226855-28-2 | Details |
Indirubin-5-sulfonate | C16H10N2O5S | 244021-67-8 | Details |
KD-3010 | C30H33F3N2O8S2 | 934760-92-6 | Details |
KRAS inhibitor-8 | C26H24ClF4N5O3 | 2022986-70-3 | Details |
COH34 analog 1 | C18H15NO3S | 314248-24-3 | Details |
CDK4/6-IN-3 | C25H31FN8 | 2366237-37-6 | Details |
GSK1521498 free base | C24H20F2N4 | 1007573-18-3 | Details |
Kv3 modulator 4 | C20H24N2O4 | 2173375-10-3 | Details |
β-NF-JQ1 | C45H42ClN5O6S | 2380000-55-3 | Details |
BRD5631 | C30H35N3O4 | 2446154-91-0 | Details |
BPN-15606 | C23H23FN6O | 1914989-49-3 | Details |
CYP17-IN-1 | C18H17FN2S | 2093317-51-0 | Details |
GW768505A free base | C27H19F4N5O3 | 501693-25-0 | Details |
LysRs-IN-2 | C17H16F3NO4 | 2170696-76-9 | Details |
LY3020371 hydrochloride | C15 H15 F2 N O5 S . Cl H | 1377615-44-5 | Details |
LY88074 Methyl ether | C22H16O4S | 63675-88-7 | Details |
LY 541850 | C9H13NO4 | 852679-76-6 | Details |
KRAS inhibitor-6 | C27H30ClF2N5O3 | 2022986-61-2 | Details |
GSK3004774 | C32H40N4O3 | 2138814-32-9 | Details |
HG-12-6 | C29H27F3N6O2S | 2222354-57-4 | Details |
GYKI 52466 dihydrochloride | C17H16ClN3O2 | 2319722-40-0 | Details |
GSK1521498 | C24H23F2N4O4P | 1426543-84-1 | Details |
BMY-43748 | C20H17F3N4O3 | 132195-65-4 | Details |
DB1976 dihydrochloride | C20H17ClN8Se | 2369663-93-2 | Details |
Ciraparantag acetate | C24H52N12O4 | 1644388-83-9 | Details |
CT-721 | C30H29ClN6O | 1388710-60-8 | Details |
FAK inhibitor 5 | C20H21N3O2S | 1426683-30-8 | Details |
Frakefamide | C30H34FN5O5 | 188196-22-7 | Details |
CFTR corrector 4 | C29H27F2NO7 | 1918142-34-3 | Details |
JAK-IN-1 | C20H24N6O2 | 1334673-53-8 | Details |
CRT0066854 hydrochloride | C24H26ClN5S | 2250019-91-9 | Details |
DHODH-IN-8 | C17H13ClN2O2 | 1148126-03-7 | Details |
DDR-TRK-1 | C26H23F3N6O | 1934246-19-1 | Details |
JAK-IN-3 | C18H20N4O3 | 1400876-94-9 | Details |
JAK-IN-5 hydrochloride | C27H32ClFN6O | 2751323-21-2 | Details |
GC 14 | C26H27NO6 | 447415-34-1 | Details |
FGI-106 | C28H38N6 | 501081-38-5 | Details |
DYRKs-IN-1 | C30H30ClN7O4 | 1387090-01-8 | Details |
DHODH-IN-15 | C15H11N3O3 | 1364791-88-7 | Details |
EMT inhibitor-2 | C24H26N2O8 | 2232228-60-1 | Details |
HDAC-IN-5 | C26H24F3N5O2S | 1314890-51-1 | Details |
hDHODH-IN-5 | C21H21F3N2O2 | 2029049-77-0 | Details |
DSP-1053 | C26H32BrNO4 | 1176326-76-3 | Details |
CDK4/6/1 Inhibitor | C28H30F2N6 | 2099128-41-1 | Details |
CRTH2-IN-1 | C21H21FN2O4S | 926661-54-3 | Details |
CXCR7 modulator 2 | C29H42N6O3 | 2227426-37-9 | Details |
Closthioamide | C29H38N6O2S6 | 1227367-59-0 | Details |
Chalcone 4 hydrate | C16H15ClO4 | 1202866-96-3 | Details |
S1PR1-MO-1 | C25H29N3O3 | 1149727-61-6 | Details |
KRAS G12C inhibitor 14 | C24H19ClF2N4O3 | 2349393-95-7 | Details |
IL-17A antagonist 3 | C33H33ClN6O4 | 2230780-65-9 | Details |
LSD1-IN-5 | C15H13BrN2O3 | 2035912-55-9 | Details |
LSD1-IN-6 | C15H13BrN2O3 | 2035912-43-5 | Details |
Lamivudine 13C,15N2 | C8H9N3O4S | 1391052-30-4 | Details |
KRN2 | C27H23ClFNO4 | 248260-75-5 | Details |
Cyclophilin inhibitor 1 | C31H39N5O7 | 1509904-96-4 | Details |
IACS-8779 | C21H25N9O10P2S2 | 2243079-26-5 | Details |
CP-060 | C30H42N2O5S | 180090-15-7 | Details |
GABAB receptor antagonist 1 | C18H24O4 | 797-17-1 | Details |
CCR7 Ligand 1 | C22H29N5O5S | 681514-83-0 | Details |
β3-AR agonist 2 | C27H38N4O7S | 340757-05-3 | Details |
L-692429 | C29H31N7O2 | 145455-23-8 | Details |
CK2/PIM1-IN-1 | C15H9NO4S2 | 292640-28-9 | Details |
EG01377 | C26H30N6O6S2 | 2227996-00-9 | Details |
Endothelial lipase inhibitor-1 | C22H22N4O4 | 1466427-02-0 | Details |
Product Total: Product Page: | ||||
68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 |